In a 68-year-old woman with untreated hypertension, diabetes mellitus, and dyslipidemia who had a 30‑minute transient ischemic attack presenting as slurred speech without weakness, dysarthria, or ataxia, and currently has a blood pressure of 160/80 mm Hg, what is the most appropriate pharmacologic management among the options: furosemide, amlodipine, metoprolol, or an angiotensin‑converting‑enzyme inhibitor?

Most Appropriate Management: ACEI (Option D)

For this 68-year-old woman with diabetes, dyslipidemia, and untreated hypertension who experienced a TIA, an ACE inhibitor is the most appropriate initial antihypertensive agent among the options provided.

Rationale

This patient has experienced a transient ischemic attack (30 minutes of transient slurred speech that resolved completely). The National Stroke Association guidelines explicitly recommend that after TIA, blood pressure should be reduced to less than 130/80 mm Hg for diabetics with an angiotensin-converting enzyme (ACE) inhibitor alone or in combination with a diuretic, or with an angiotensin receptor blocker (category 1) 1. Her current BP of 160/80 mm Hg exceeds this target.

Why ACEI is the Best Choice:

• Guideline-directed therapy: Multiple guidelines specifically recommend ACE inhibitors as first-line agents for hypertension management after TIA/stroke, particularly in diabetic patients 1, 2, 3, 4

• Dual benefit in diabetes: ACE inhibitors provide both stroke prevention and renoprotection in diabetic patients, reducing progression of diabetic kidney disease 5, 6, 7

• Target BP for diabetics post-TIA: The goal is <130/80 mm Hg in diabetic patients after TIA 1, 4, and ACE inhibitors are the recommended first-line agent to achieve this

• Proven mortality benefit: ACE inhibitors reduce cardiovascular events and recurrent stroke risk in this population 2, 3

Why NOT the Other Options:

A. Lasix (Furosemide): This is a loop diuretic indicated for edema and fluid overload 8. This patient has no clinical evidence of heart failure or volume overload. While thiazide diuretics are recommended in combination with ACE inhibitors for post-TIA hypertension management 1, 4, loop diuretics like furosemide are not the appropriate choice for uncomplicated hypertension management.

B. Amlodipine: While calcium channel blockers can be used for hypertension, guidelines show limited data on their efficacy specifically for secondary stroke prevention 4. They are considered reasonable when additional agents are needed but are not the preferred first-line choice in diabetic patients post-TIA.

C. Metoprolol: Beta-blockers are not specifically recommended as first-line agents for hypertension management after TIA/stroke unless there are compelling indications such as coronary artery disease or heart failure 2, 3. This patient has no documented cardiac disease.

Clinical Approach

Immediate management:

1. Initiate ACE inhibitor therapy (e.g., ramipril, perindopril, or lisinopril)
2. Target BP <130/80 mm Hg given her diabetes 1, 4
3. Monitor renal function and potassium within first 3 months 5

Additional essential interventions (beyond the question scope but critical):

• Antiplatelet therapy (aspirin) should be initiated immediately 2, 3
• Statin therapy for dyslipidemia 2, 4
• Diabetes optimization
• Complete stroke workup including carotid imaging and cardiac evaluation

Important Caveats

• Timing: Guidelines suggest it is usually advisable to wait 7-14 days before starting blood pressure-lowering medication after TIA 1, though this patient is presenting after symptom resolution, making immediate initiation reasonable

• Combination therapy: Most patients will require multiple agents to reach target BP 5, 4. If ACE inhibitor monotherapy is insufficient, adding a thiazide diuretic (not a loop diuretic) would be the next step 1, 4

• Monitoring: Check renal function and electrolytes within 3 months of initiation, then every 6 months 5